Copyright @ 2022 Public Health Association of BC. All rights reserved. ImmunizeBC is located on the unceded, ancestral and traditional lands of the xʷməθkʷəy̓əm (Musqueam), Səl̓ílwətaʔ (Tsleil-Waututh), and Skwxwú7mesh (Squamish) Nations. We acknowledge that our work goes beyond the places we live and impacts the lives of nations across British Columbia and Turtle Island. As a step towards reconciliation, this acknowledgement is one part of our commitment to the Calls to Action of the Truth and Reconciliation Commission of Canada. CDC has issued guidance on the SHINGRIX dosing schedule2,3,*
*In a phase 3 clinical study designed to help establish the dosing interval for SHINGRIX, all primary endpoints were met for dosing at a 0- and 6-month interval when compared to dosing at a 0- and 2-month interval. However, a co-primary endpoint (noninferiority) of the immune response was missed for dosing at a 0- and 12-month interval. (The upper limit of the 97.5% confidence interval was 1.53, above the predefined limit of <1.5.)4 GSK has not studied the safety or immune response of 3 doses of SHINGRIX in the indicated population (patients ≥50 years of age).1 CDC=Centers for Disease Control and Prevention. Prescribing SHINGRIXWhen referring patients to a pharmacy, e-prescribe SHINGRIX. The pharmacy will notify your office when the patient has received the first dose. See how you can make the most of your EHR system here.
|